Omeros at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Omeros exhibits at Booth 1647 at ASH 2026 in New Orleans. Omeros supports a symposium on a complication of allogeneic stem cell transplant. Through case discussion, it covers endothelial injury, the complement system and transplant-associated thrombotic microangiopathy.
| Organization | ASH 2026 Attendance |
|---|---|
Omeros Seattle, WA | |
Biopharmaceutical company developing complement-targeting and other immunology therapies, including for transplant-associated thrombotic microangiopathy. | Booth Exhibiting at Booth 1647 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 7:00pm–10:00pm Cases and Conversations: Endothelial Injury, Complement, and TA-TMA After Allogeneic Stem Cell Transplant Picking graft sources such as expanded cord blood, and treating transplant-associated thrombotic microangiopathy with a newly approved complement inhibitor. |
Find decision makers at Omeros
Tell us what you sell and we’ll find the people at Omeros most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction